- Home
- VANI vs ECOR Comparison
VANI vs ECOR Comparison
Compare VANI & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- ECOR
- Stock Information
- Founded
- VANI 1998
- ECOR 2005
- Country
- VANI United States
- ECOR United States
- Employees
- VANI N/A
- ECOR N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- VANI Health Care
- ECOR Health Care
- Exchange
- VANI Nasdaq
- ECOR Nasdaq
- Market Cap
- VANI 65.2M
- ECOR 57.5M
- IPO Year
- VANI 2014
- ECOR 2018
- Fundamental
- Price
- VANI $1.07
- ECOR $6.69
- Analyst Decision
- VANI Strong Buy
- ECOR Strong Buy
- Analyst Count
- VANI 1
- ECOR 2
- Target Price
- VANI $4.00
- ECOR $25.50
- AVG Volume (30 Days)
- VANI 102.7K
- ECOR 216.5K
- Earning Date
- VANI 03-31-2025
- ECOR 03-12-2025
- Dividend Yield
- VANI N/A
- ECOR N/A
- EPS Growth
- VANI N/A
- ECOR N/A
- EPS
- VANI N/A
- ECOR N/A
- Revenue
- VANI N/A
- ECOR $25,182,000.00
- Revenue This Year
- VANI N/A
- ECOR $40.88
- Revenue Next Year
- VANI N/A
- ECOR $48.01
- P/E Ratio
- VANI N/A
- ECOR N/A
- Revenue Growth
- VANI N/A
- ECOR 57.09
- 52 Week Low
- VANI $1.03
- ECOR $5.32
- 52 Week High
- VANI $2.22
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- VANI 41.41
- ECOR 19.00
- Support Level
- VANI $1.06
- ECOR $6.57
- Resistance Level
- VANI $1.16
- ECOR $8.25
- Average True Range (ATR)
- VANI 0.04
- ECOR 0.92
- MACD
- VANI 0.01
- ECOR -0.15
- Stochastic Oscillator
- VANI 28.85
- ECOR 4.82
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.